A recent report by States Allied Market Research estimates the overall market for connected health or mobile healthcare will reach nearly $60 billion by 2020 most of which may come from blood glucose meters and cardiac monitoring devices.
“We’ve all seen how mobile devices and apps have changed the way we live, work, and play and how they will foster a significant change for the better in healthcare,” said Rob McCray, CEO for the Wireless Life Science Alliance (WLSA) located in San Diego.
Mobile healthcare or referred to as connected health is currently driving businesses around the world to develop and design fitness and wellness apps that measure workouts or track basic health data. True connected health apps needed to be used to diagnose or track diseases or other conditions will need to meet certain FDA guidelines.
FDA has published final guidance on mobile medical apps but there are still unanswered questions. To help mobile app developers find out the answers and to learn about FDA requirements for producing higher risk medical apps, WLSA has joined a consortium of six leading universities, more than a dozen industry trade associations, professional societies, and the FDA to collaborate on developing a series of educational programs.
WLSA is taking on an important role in supporting the educational program “MMA Roadshow: Managing App Development under FDA Regulation”. The University of California San Diego is one of eight universities chosen to host a workshop that is being organized by the legal firm Epstein Becker Green that will be held on January 27, 2014.
For more information on WLSA, go to http://wirelesslifesciences.org or go to vonliebigcenter@eng.ucsd.edu for information on the MMA Roadshow: Managing App Development under FDA Regulation.